Latest Stem Cells news
Allogeneic HCT Feasible in Older Patients With Myelodysplastic Syndrome
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
posted December 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Itacitinib Helps Prevent Graft Versus Host Disease in Stem Cell Transplant Recipients
posted December 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy 
A-Fib Occurs Frequently in Patients With Multiple Myeloma Undergoing Stem Cell Transplant Monthly Specialist Briefings
Stay Connected
